multiple dose

DRUG3 trials

Sponsors

The First Hospital of Jilin University, Shulan (Hangzhou) Hospital, Knopp Biosciences

Conditions

Amyotrophic Lateral SclerosisAnkylosing SpondylitisChronic hepatitis B

Early Phase 1

A study on the safety, tolerance, pharmacokinetics and pharmacodynamics of EPI-003T injection in the treatment of chronic hepatitis B subjects who have been treated with nucleoside (acid) analogues

Active, not recruitingChiCTR2500110861

Shulan (Hangzhou) HospitalChronic hepatitis B

Start: 2025-10-22Updated: 2025-10-27

Phase 1

Dexpramipexole Japanese PK Study

CompletedNCT01424163

Knopp BiosciencesAmyotrophic Lateral Sclerosis

Start: 2011-08-31End: 2012-02-29Updated: 2021-06-22

A single-center, randomized, double-blind, placebo-controlled multiple-ascending dose study of QX002N injection

Active, not recruitingChiCTR2000034090

The First Hospital of Jilin UniversityAnkylosing Spondylitis

Start: 2020-08-01Updated: 2020-06-29